DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,450,695 | -6.1% | 943,208 | +17.9% | 0.00% | 0.0% |
| Q2 2023 | $9,000,368 | +18.3% | 800,225 | +21.1% | 0.00% | 0.0% |
| Q1 2023 | $7,610,616 | +143931.3% | 660,630 | +44.9% | 0.00% | +50.0% |
| Q4 2022 | $5,284 | -99.9% | 455,988 | +58.5% | 0.00% | +100.0% |
| Q3 2022 | $3,653,000 | +543.1% | 287,601 | +247.4% | 0.00% | – |
| Q2 2022 | $568,000 | +17.4% | 82,790 | +64.7% | 0.00% | – |
| Q1 2022 | $484,000 | +13.1% | 50,278 | +39.6% | 0.00% | – |
| Q4 2021 | $428,000 | – | 36,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |